V

vTv Therapeutics

D
VTVT
USD
0.85
(6.0369%)
Market Closed
120.000
Volume
-0.21
EPS
-
Div Yield
-2.185944
P/E
36,322,555.01
Market Cap
Today
6.0369%
1 Week
-0.201%
1 Month
-5.327%
6 Months
-27.524%
12 Months
-16.963%
Year To Date
30.393%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
P
PULM
-0.06
(-2.7523%)
USD
A
ALT
0.15
(2.0188%)
USD
C
CALA
(%)
USD
A
AVID
(%)
USD
S
SGMO
0.0617
(7.3584%)
USD
A
ADVM
0.5
(7.1633%)
USD
I
IMGN
(%)
USD

Title:
vTv Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Do you need help or have a question?
Contact Us